companies / aqemia-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-16 json
| total_raised | 32,400,00032.4M | ○ |
|---|---|---|
| founded | 2019 | |
| hq | Paris, France | |
| industry | unknown | |
| stage | series-a |
AQEMIA advances medicine discovery by combining generative AI with deep physics to develop new drugs. The company serves pharmaceutical researchers and organizations seeking to overcome conventional discovery limitations. Its differentiator is the integration of physics-based AI engines that enable drug development at scale beyond.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-01-01 | series-a | 32,400,00032.4M | null | ○ |
Netlify, Next.js, React, Webpack
| fact | status | src |
|---|---|---|
| Series A, $32.4M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |